Piperacillin/tazobactam in the treatment of moderate and severe pulmonary infection in recipients of renal transplantation:a report of 35 cases
- VernacularTitle:哌拉西林/他佐巴坦治疗肾移植患者中重度肺部感染(附35例报告)
- Author:
Meisheng ZHOU
;
Zhilian MIN
;
Youhua ZHU
- Publication Type:Journal Article
- Keywords:
Kidney transplantation;
Antibiotics;
Lung;
Infection
- From:
Chinese Journal of Organ Transplantation
1996;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and safety of piperacillin/tazobactam in the treatment of moderate and severe pulmonary infection (MSPI). Methods The clinical data of 35 patients with MSPI following kidney transplantation were retrospectively analyzed.Results Thirty-five cases out of the 35 MSPI patients ( 97.14 % ) was rescued successfully. The overall clinical efficacy rate of piperacillin/tazobactam was 91.43 % (32/35). The bacterial clearance rate was 92.59 % . The incidence of adverse reaction was 8.57 % (3/35).Conclusions Intensive care and active measures should be given to the MSPI patients after kidney transplantation. The key points of successful treatment involve the in time application of effective antibiotics,the adjustment of immunosuppressant and the correction of hypoproteinemia.
